Highlights of the 17th European AIDS Clinical Society (EACS) Conference, 6-9 November 2019, Basel, Switzerland.
作者信息
Psomas Christina K, Kinloch Sabine
机构信息
Department of Infectious Diseases and Internal Medicine, European Hospital Marseille, Marseille, France.
Royal Free Hospital, Department of Infection and Immunity and Royal Free Campus, University College London, UK.
出版信息
J Virus Erad. 2020 Feb 20;6(1):38-44. doi: 10.1016/S2055-6640(20)30010-8.
Abstract
摘要
相似文献
1
Highlights of the 17th European AIDS Clinical Society (EACS) Conference, 6-9 November 2019, Basel, Switzerland.2019年11月6日至9日于瑞士巴塞尔举行的第17届欧洲艾滋病临床学会（EACS）会议亮点。
J Virus Erad. 2020 Feb 20;6(1):38-44. doi: 10.1016/S2055-6640(20)30010-8.
2
Abstracts of the 17th European AIDS Conference, Basel, Switzerland, 6-9 November 2019.2019年11月6日至9日于瑞士巴塞尔召开的第17届欧洲艾滋病大会摘要。
HIV Med. 2019 Nov;20 Suppl 9:3-316. doi: 10.1111/hiv.12814.
3
How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?欧洲艾滋病临床学会认知筛查问题在预测老龄化、治疗良好的 HIV 阳性人群认知障碍方面有多大帮助？
HIV Med. 2020 May;21(5):342-348. doi: 10.1111/hiv.12828. Epub 2019 Dec 27.
4
Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.2017 年欧洲艾滋病临床学会（EACS）成人 HIV 阳性感染者治疗指南第 9.0 版要点。
HIV Med. 2018 May;19(5):309-315. doi: 10.1111/hiv.12600. Epub 2018 Mar 1.
5
Abstracts of the 12th European AIDS Conference/EACS, 11-14 November 2009, Cologne, Germany.2009年11月11日至14日于德国科隆举行的第12届欧洲艾滋病大会/欧洲艾滋病临床学会会议摘要
HIV Med. 2009 Oct;10 Suppl 2:1-246. doi: 10.1111/j.1468-1293.2009.00789.x.
6
Highlights from the 13th European AIDS Conference (EACS).第13届欧洲艾滋病大会（EACS）亮点
Germs. 2011 Dec 24;1(1):9-11. doi: 10.11599/germs.2012.1003.
7
Environment and Health - Bridging South, North, East and West. Basel, Switzerland 19-23 August 2013.环境与健康——连接南、北、东、西方。瑞士巴塞尔，2013 年 8 月 19 日至 23 日。
Environ Health Perspect. 2013 Aug 19;121(S1). doi: 10.1289/ehp.ehbasel13.
8
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons.2015年欧洲艾滋病临床学会（EACS）成人HIV阳性感染者治疗指南要点
HIV Med. 2016 Feb;17(2):83-8. doi: 10.1111/hiv.12322. Epub 2015 Nov 8.
9
Meeting report of the 10th European AIDS Conference (EACS) 17-20 November 2005.2005年11月17日至20日第十届欧洲艾滋病大会（EACS）会议报告
J HIV Ther. 2005 Dec;10(4):79-80.
10
European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16-17 November 2016: a summary.欧洲艾滋病临床学会第二次标准护理会议，2016 年 11 月 16-17 日，布鲁塞尔：摘要。
HIV Med. 2018 Feb;19(2):77-80. doi: 10.1111/hiv.12559. Epub 2017 Oct 27.
本文引用的文献
1
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort.在西班牙一个大型队列中，与基于整合酶抑制剂的三联疗法相比，换用多替拉韦加rilpivirine或拉米夫定的HIV感染者因治疗失败而停药的时间更短。
Infect Dis Ther. 2022 Jun;11(3):1177-1192. doi: 10.1007/s40121-022-00630-y. Epub 2022 Apr 11.
2
HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection.在原发性 HIV-1 感染时开始使用多替拉韦为基础的三联复方方案的男性的血浆和精浆中的 HIV-1 RNA 动力学。
J Infect Dis. 2022 Jan 5;225(1):116-120. doi: 10.1093/infdis/jiab336.
3
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis.初治 HIV 患者的双重治疗与三重治疗失败风险：系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Jan;27(1):28-35. doi: 10.1016/j.cmi.2020.09.048. Epub 2020 Oct 5.
4
Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir.心包脂肪组织体积与人类免疫缺陷病毒状态及先前使用司他夫定、去羟肌苷或茚地那韦独立相关。
J Infect Dis. 2020 Jun 16;222(1):54-61. doi: 10.1093/infdis/jiaa057.
5
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.抗逆转录病毒治疗起始后体重增加：随机对照临床试验中的危险因素。
Clin Infect Dis. 2020 Sep 12;71(6):1379-1389. doi: 10.1093/cid/ciz999.
6
Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.在START（抗逆转录病毒治疗的战略时机）试验中，HIV阳性参与者立即与延迟启动抗逆转录病毒治疗时心血管疾病风险因素的变化。
J Am Heart Assoc. 2017 May 22;6(5):e004987. doi: 10.1161/JAHA.116.004987.
Zotero 插件